Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 06, 2018 13:04 ET | Source: Curetis

Curetis Unyvero HPN Kartusche erhält Zulassung durch Singapore Health Sciences Authority; Fortschritte bei Sepsis Host Response Test

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Curetis Unyvero HPN Kartusche erhält...
February 06, 2018 13:04 ET | Source: Curetis

Curetis Unyvero HPN Application Receives Singapore Health Sciences Authority Approval; Updates on Sepsis Host Response Test

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Curetis Unyvero HPN Application...
February 05, 2018 13:09 ET | Source: Curetis

Curetis Gruppe: Ares Genetics erhält Förderzusage für EUR 1,6 Mio. Projekt, Curetis gibt vorläufiges Finanzergebnis für 2017 bekannt

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Curetis Gruppe: Ares Genetics erhält...
February 05, 2018 13:09 ET | Source: Curetis

Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Curetis Group: Ares Genetics Receives...
January 10, 2018 01:00 ET | Source: Curetis

Curetis und MGI bauen strategische Partnerschaft für NGS-basierte molekulare Mikrobiologie aus

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Curetis...
January 10, 2018 01:00 ET | Source: Curetis

Curetis and MGI Advance Strategic Partnership in NGS-Based Molecular Microbiology

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ...
January 08, 2018 01:01 ET | Source: Curetis

Curetis erwartet baldige Entscheidung der FDA über De Novo-Zulassungsantrag

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} - Prüfung des Unyvero Systems und der...
January 08, 2018 01:01 ET | Source: Curetis

Curetis Expects Near-Term FDA Decision on De Novo Request

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} - Review of the Unyvero System and...
December 19, 2017 02:00 ET | Source: Curetis

Curetis gibt Teilnahme an Investoren- und Wissenschaftskonferenzen im ersten Quartal 2018 bekann

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Amsterdam, Niederlande, und...
December 19, 2017 02:00 ET | Source: Curetis

Curetis To Attend Key Investor and Scientific Conferences In The First Quarter 2018

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Amsterdam, the Netherlands, and...